Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1460-1462
doi: 10.1161/01.CIR.0000060808.79274.0C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, D. R.
Right arrow Articles by Freeman, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, D. R.
Right arrow Articles by Freeman, G. L.
Related Collections
Right arrow Congestive
Right arrowRelated Article

(Circulation. 2003;107:1460.)
© 2003 American Heart Association, Inc.


Editorial

Proinflammatory Cytokines

Predictors of a Failing Heart?

David R. Murray, MD; Gregory L. Freeman, MD

From the Department of Medicine/Cardiology, University of Texas Health Science Center at San Antonio, and South Texas Veterans Healthcare System, Audie L. Murphy Division, San Antonio.

Correspondence to David R. Murray, MD, Department of Medicine/Cardiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, MSC 7872, San Antonio, TX 78229 to 3900. E-mail MurrayD@uthscsa.edu


Key Words: Editorials • heart failure • cytokines • tumor necrosis factor • interleukins


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Congestive heart failure (CHF) is a complex clinical syndrome characterized by exercise intolerance, fatigability, dyspnea, and volume retention occurring as a consequence of myocardial injury and subsequent dysfunction. Progression of this disease is thought to be mediated by neurohormones, such as norepinephrine and angiotensin II, by virtue of the toxic effects that they exert on the heart and the peripheral vasculature.1 These mediators are capable of altering the function and structure of the left ventricle (LV), ie, remodeling, via direct effects on cardiomyocyte biology and extracellular matrix composition and via indirect effects on the loading conditions under which the heart must function.1 Indeed, antagonizing the activation of the renin angiotensin system and the adrenergic system has become the mainstay of contemporary pharmacologic management of patients with this disease.1,2 ß-blockers and angiotensin converting enzyme inhibitors have been shown to improve ventricular performance and clinical outcomes in patients with symptomatic heart failure due to LV systolic dysfunction, thus supporting the "neurohormonal hypothesis".1,2

See p 1486

Another group of peptides, the proinflammatory cytokines, are upregulated in patients with CHF and have been implicated in the pathophysiology of this disease. The most well studied of these cytokines is tumor necrosis factor (TNF).3 Comparatively less is known about interleukin (IL)-1, IL-2, IL-6, and interferon-{gamma} in the setting of heart failure. Cardiomyocytes as well as other nucleated cell types within the myocardium are capable of synthesizing TNF in response to various forms of cardiac stress such as myocardial infarction4 and LV pressure or volume overload.5 Neither . . . [Full Text of this Article]


Related Article:

Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study
Ramachandran S. Vasan, Lisa M. Sullivan, Ronenn Roubenoff, Charles A. Dinarello, Tamara Harris, Emelia J. Benjamin, Douglas B. Sawyer, Daniel Levy, Peter W.F. Wilson, and Ralph B. D’Agostino
Circulation 2003 107: 1486-1491. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
J. Nutr.Home page
T. Al-Sarraj, H. Saadi, M. C. Calle, J. S. Volek, and M. L. Fernandez
Carbohydrate Restriction, as a First-Line Dietary Intervention, Effectively Reduces Biomarkers of Metabolic Syndrome in Emirati Adults
J. Nutr., September 1, 2009; 139(9): 1667 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Puglisi and M. L. Fernandez
Modulation of C-Reactive Protein, Tumor Necrosis Factor-{alpha}, and Adiponectin by Diet, Exercise, and Weight Loss
J. Nutr., December 1, 2008; 138(12): 2293 - 2296.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Liuba, H. Ahlmroth, L. Jonasson, A. Englund, A. Jonsson, K. Safstrom, and H. Walfridsson
Source of inflammatory markers in patients with atrial fibrillation
Europace, July 1, 2008; 10(7): 848 - 853.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
G. Mercuro, C. Cadeddu, A. Piras, M. Dessi, C. Madeddu, M. Deidda, R. Serpe, E. Massa, and G. Mantovani
Early Epirubicin-Induced Myocardial Dysfunction Revealed by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers
Oncologist, September 1, 2007; 12(9): 1124 - 1133.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Hara, K.-i. Yuhki, T. Fujino, T. Yamada, K. Takayama, S. Kuriyama, O. Takahata, H. Karibe, Y. Okada, C.-Y. Xiao, et al.
Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking the Prostaglandin I2 Receptor
Circulation, July 5, 2005; 112(1): 84 - 92.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. G. Li, D. Gavrila, X. Liu, L. Wang, S. Gunnlaugsson, L. L. Stoll, M. L. McCormick, C. D. Sigmund, C. Tang, and N. L. Weintraub
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-{kappa}B Activation in Human Endothelial Cells
Circulation, May 11, 2004; 109(18): 2221 - 2226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Feingold, M. S. Kim, J. Shigenaga, A. Moser, and C. Grunfeld
Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E201 - E207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. A. Hatoum, H. Miura, and D. G. Binion
The vascular contribution in the pathogenesis of inflammatory bowel disease
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1791 - H1796.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware, X. Fang, and M. A. Matthay
Protein C and thrombomodulin in human acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L514 - L521.
[Abstract] [Full Text] [PDF]